Market Cap 1.39B
Revenue (ttm) 450.71M
Net Income (ttm) -88.88M
EPS (ttm) N/A
PE Ratio 83.38
Forward PE 18.42
Profit Margin -19.72%
Debt to Equity Ratio -1.73
Volume 4,134,800
Avg Vol 4,236,588
Day's Range N/A - N/A
Shares Out 210.74M
Stochastic %K 38%
Beta 0.80
Analysts Strong Sell
Price Target $20.60

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phas...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 859 1302
Fax: 919 859 1314
Address:
4505 Emperor Boulevard, Suite 200, Durham, United States
Ttubular
Ttubular Feb. 4 at 4:13 AM
$BCRX is it asking too much too have 32 Green Day’s in a row?
1 · Reply
2YrsEarly
2YrsEarly Feb. 4 at 2:33 AM
$BCRX This is how Vegas feels if we ever make through all this BS and hit $15.
1 · Reply
Fergus20
Fergus20 Feb. 4 at 2:26 AM
$SMCI why is this worth more than $BCRX?
1 · Reply
Fergus20
Fergus20 Feb. 4 at 2:24 AM
$PYPL $BCRX is better than this
0 · Reply
Fergus20
Fergus20 Feb. 4 at 2:10 AM
$NVO why does this have a higher market cap than $BCRX?
0 · Reply
Smnorgy1
Smnorgy1 Feb. 4 at 1:16 AM
$BCRX Only Babu can step it up here Fergus. We are less than bottomed minions in a sea of privilege.
0 · Reply
Fergus20
Fergus20 Feb. 3 at 11:18 PM
$BCRX why can’t anyone else ever step it up here?
0 · Reply
Fergus20
Fergus20 Feb. 3 at 11:17 PM
$BCRX remember when I got us trending the other day?
0 · Reply
Fergus20
Fergus20 Feb. 3 at 11:08 PM
$BCRX seriously…why is this so low?
0 · Reply
BillsBowTie
BillsBowTie Feb. 3 at 11:05 PM
$BCRX Island moving Gali along and raising $9M in offering. Charlie has bigger fish to fry now but glad Island is finding a pathway forward with a once promising in-house asset. Island seems like such a small team and I feel we heard more from them than we ever heard from our own - but it is what it is. https://www.islandpharmaceuticals.com/site/pdf/5168bc14-f2d0-437a-b6cb-a0643305e0bc/FDA-confirms-Galidesivir-approval-pathway.pdf?Platform=ListPage https://www.islandpharmaceuticals.com/site/pdf/37b8e911-9a66-46f9-b577-80459ed17e13/9m-placement-to-advance-US-biodefence-opportunity.pdf?Platform=ListPage
3 · Reply
Latest News on BCRX
BioCryst to Present at Upcoming Investor Conference

Nov 5, 2025, 7:00 AM EST - 3 months ago

BioCryst to Present at Upcoming Investor Conference


BioCryst Pharmaceuticals, Inc. (BCRX) M&A Call Transcript

Oct 14, 2025, 1:16 PM EDT - 4 months ago

BioCryst Pharmaceuticals, Inc. (BCRX) M&A Call Transcript


BioCryst to buy Astria Therapeutics in $700 million deal

Oct 14, 2025, 7:35 AM EDT - 4 months ago

BioCryst to buy Astria Therapeutics in $700 million deal

ATXS


BioCryst: Blue Light Special In Small Cap Biotech Aisle

Sep 29, 2025, 2:53 AM EDT - 4 months ago

BioCryst: Blue Light Special In Small Cap Biotech Aisle


BioCryst Announces Departure of Dr. Helen Thackray

Aug 11, 2025, 7:00 AM EDT - 6 months ago

BioCryst Announces Departure of Dr. Helen Thackray


ORLADEYO® (berotralstat) Approved in Colombia

Jun 13, 2025, 7:00 AM EDT - 8 months ago

ORLADEYO® (berotralstat) Approved in Colombia


BioCryst to Present at Upcoming Investor Conferences

May 27, 2025, 7:00 AM EDT - 9 months ago

BioCryst to Present at Upcoming Investor Conferences


BioCryst: Strong Opportunity For A Double With A Proven Therapy

May 5, 2025, 2:05 PM EDT - 9 months ago

BioCryst: Strong Opportunity For A Double With A Proven Therapy


BioCryst Appoints Steve Frank to Board of Directors

May 1, 2025, 7:00 AM EDT - 9 months ago

BioCryst Appoints Steve Frank to Board of Directors


BioCryst to Report First Quarter 2025 Financial Results on May 5

Apr 21, 2025, 7:00 AM EDT - 10 months ago

BioCryst to Report First Quarter 2025 Financial Results on May 5


BioCryst: Orladeyo's Expansion Is Just Getting Started

Feb 26, 2025, 9:09 AM EST - 1 year ago

BioCryst: Orladeyo's Expansion Is Just Getting Started


Ttubular
Ttubular Feb. 4 at 4:13 AM
$BCRX is it asking too much too have 32 Green Day’s in a row?
1 · Reply
2YrsEarly
2YrsEarly Feb. 4 at 2:33 AM
$BCRX This is how Vegas feels if we ever make through all this BS and hit $15.
1 · Reply
Fergus20
Fergus20 Feb. 4 at 2:26 AM
$SMCI why is this worth more than $BCRX?
1 · Reply
Fergus20
Fergus20 Feb. 4 at 2:24 AM
$PYPL $BCRX is better than this
0 · Reply
Fergus20
Fergus20 Feb. 4 at 2:10 AM
$NVO why does this have a higher market cap than $BCRX?
0 · Reply
Smnorgy1
Smnorgy1 Feb. 4 at 1:16 AM
$BCRX Only Babu can step it up here Fergus. We are less than bottomed minions in a sea of privilege.
0 · Reply
Fergus20
Fergus20 Feb. 3 at 11:18 PM
$BCRX why can’t anyone else ever step it up here?
0 · Reply
Fergus20
Fergus20 Feb. 3 at 11:17 PM
$BCRX remember when I got us trending the other day?
0 · Reply
Fergus20
Fergus20 Feb. 3 at 11:08 PM
$BCRX seriously…why is this so low?
0 · Reply
BillsBowTie
BillsBowTie Feb. 3 at 11:05 PM
$BCRX Island moving Gali along and raising $9M in offering. Charlie has bigger fish to fry now but glad Island is finding a pathway forward with a once promising in-house asset. Island seems like such a small team and I feel we heard more from them than we ever heard from our own - but it is what it is. https://www.islandpharmaceuticals.com/site/pdf/5168bc14-f2d0-437a-b6cb-a0643305e0bc/FDA-confirms-Galidesivir-approval-pathway.pdf?Platform=ListPage https://www.islandpharmaceuticals.com/site/pdf/37b8e911-9a66-46f9-b577-80459ed17e13/9m-placement-to-advance-US-biodefence-opportunity.pdf?Platform=ListPage
3 · Reply
Fergus20
Fergus20 Feb. 3 at 10:47 PM
$CMG you guys should buy $BCRX. BioWar begins tomorrow…huge Wallstreet Bets post on it an hour ago. Most undervalued stock on the market.
0 · Reply
Ttubular
Ttubular Feb. 3 at 10:28 PM
$BCRX oh my god how did we finish green?
0 · Reply
Fergus20
Fergus20 Feb. 3 at 10:26 PM
$AVGO you all should buy $BCRX! BioWar 2.0 starts tomorrow! WallstreetBets has spoken!
1 · Reply
Fergus20
Fergus20 Feb. 3 at 10:25 PM
$AMD move your money to $BCRX!!! BioWar 2.0 starts tomorrow!!!!
0 · Reply
Fergus20
Fergus20 Feb. 3 at 10:24 PM
$BCRX will Charlie ever buy some shares?
0 · Reply
Smnorgy1
Smnorgy1 Feb. 3 at 9:07 PM
$BCRX Why doesn't Babu invent something integral to the success of Microsoft or Nvidia, for once!???
0 · Reply
Dpst2022
Dpst2022 Feb. 3 at 8:17 PM
$BCRX @doublebtx needs to stop crying like a little kid and complaining about she share price daily. Take your own advice, same way you told me to stop complaining.
0 · Reply
SNOB_ORDER
SNOB_ORDER Feb. 3 at 8:14 PM
$BCRX New US patent --"US20260028389 - FUSION PROTEIN INHIBITORS OF KLK5" --
2 · Reply
joooiink
joooiink Feb. 3 at 6:39 PM
$BCRX $NIO i don’t know what gains feel like anymore
1 · Reply
Smnorgy1
Smnorgy1 Feb. 3 at 6:30 PM
$BCRX Fergus, emergency, post on all tech boards as they rotate. Bring them over here!
1 · Reply
joooiink
joooiink Feb. 3 at 5:07 PM
0 · Reply
Paulzk
Paulzk Feb. 3 at 5:03 PM
$BCRX In the same way that the invention of semiconductors made today’s smartphones, computers and electronics possible, topoconductors and the new type of chip they enable offer a path to developing quantum systems that can scale to a million qubits and are capable of tackling the most complex industrial and societal problems, Microsoft said. https://news.microsoft.com/source/features/innovation/microsofts-majorana-1-chip-carves-new-path-for-quantum-computing/
0 · Reply